{"pmid":32330288,"title":"Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic.","text":["Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic.","With the developing COVID-19 pandemic (caused by the novel zoonotic SARS-CoV-2 coronavirus), the UK population are urged to follow Government advice on managing symptoms and reducing viral transmission (1). Unusually, patients with sickle cell anaemia (HbSS genotype) have been explicitly mentioned in this as a group at increased risk due to their non-functioning spleen (2). Unfortunately, there is no specific advice for patients with sickle cell disease of other genotypes, thalassaemia and other inherited anaemias. Many of these are at increased risk of fulminant bacterial infection, and therefore may erroneously self-isolate if their fever is mistakenly attributed to a viral cause, delaying potentially life-saving antibiotic therapy.","Br J Haematol","Roy, Noemi Ba","Telfer, Paul","Eleftheriou, Perla","de la Fuente, Josu","Drasar, Emma","Shah, Farrukh","Roberts, David","Atoyebi, Wale","Trompeter, Sara","Mark Layton, D","Lugthart, Sanne","Stuart-Smith, Sara","Chakravorty, Subarna","Wright, Josh","Porter, John","Inusa, Baba","Howard, Jo","32330288"],"abstract":["With the developing COVID-19 pandemic (caused by the novel zoonotic SARS-CoV-2 coronavirus), the UK population are urged to follow Government advice on managing symptoms and reducing viral transmission (1). Unusually, patients with sickle cell anaemia (HbSS genotype) have been explicitly mentioned in this as a group at increased risk due to their non-functioning spleen (2). Unfortunately, there is no specific advice for patients with sickle cell disease of other genotypes, thalassaemia and other inherited anaemias. Many of these are at increased risk of fulminant bacterial infection, and therefore may erroneously self-isolate if their fever is mistakenly attributed to a viral cause, delaying potentially life-saving antibiotic therapy."],"journal":"Br J Haematol","authors":["Roy, Noemi Ba","Telfer, Paul","Eleftheriou, Perla","de la Fuente, Josu","Drasar, Emma","Shah, Farrukh","Roberts, David","Atoyebi, Wale","Trompeter, Sara","Mark Layton, D","Lugthart, Sanne","Stuart-Smith, Sara","Chakravorty, Subarna","Wright, Josh","Porter, John","Inusa, Baba","Howard, Jo"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330288","week":"202017|Apr 20 - Apr 26","doi":"10.1111/bjh.16687","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"_version_":1664996914804817920,"score":8.518259,"similar":[{"pmid":32244059,"pmcid":"PMC7156157","title":"SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes.","text":["SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes.","Ever since the first case was reported at the end of 2019, the SARS-COV-2 virus and associated lung disease COVID-19 has spread throughout the world and has become a pandemic. In particular, the high transmission rate of the virus has made it a threat to public health globally. Currently, there is no proven effective therapy against the virus, and the impact on other diseases is also uncertain, especially inherited arrhythmia syndrome. Arrhythmogenic effect of COVID-19 can be expected, potentially contributing to disease outcome. This may be of importance for patients with an increased risk for cardiac arrhythmias, either secondary to acquired conditions or co-morbidities or consequent to inherited syndromes. Management of patients with inherited arrhythmia syndromes such as Long QT syndrome, Brugada syndrome, Short QT syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia in the setting of the COVID-19 pandemic may prove particularly challenging. Depending on the inherited defect involved, these patients may be susceptible to pro-arrhythmic effects of COVID-19-related issues such as fever, stress, electrolyte disturbances and use of antiviral drugs. We here describe the potential COVID-19 associated risks and therapeutic considerations for patients with distinct inherited arrhythmia syndromes and provide recommendations, pending local possibilities, for their monitoring and management during this pandemic.","Heart Rhythm","Wu, Cheng-I","Postema, Pieter G","Arbelo, Elena","Behr, Elijah R","Bezzina, Connie R","Napolitano, Carlo","Robyns, Tomas","Probst, Vincent","Schulze-Bahr, Eric","Remme, Carol Ann","Wilde, Arthur A M","32244059"],"abstract":["Ever since the first case was reported at the end of 2019, the SARS-COV-2 virus and associated lung disease COVID-19 has spread throughout the world and has become a pandemic. In particular, the high transmission rate of the virus has made it a threat to public health globally. Currently, there is no proven effective therapy against the virus, and the impact on other diseases is also uncertain, especially inherited arrhythmia syndrome. Arrhythmogenic effect of COVID-19 can be expected, potentially contributing to disease outcome. This may be of importance for patients with an increased risk for cardiac arrhythmias, either secondary to acquired conditions or co-morbidities or consequent to inherited syndromes. Management of patients with inherited arrhythmia syndromes such as Long QT syndrome, Brugada syndrome, Short QT syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia in the setting of the COVID-19 pandemic may prove particularly challenging. Depending on the inherited defect involved, these patients may be susceptible to pro-arrhythmic effects of COVID-19-related issues such as fever, stress, electrolyte disturbances and use of antiviral drugs. We here describe the potential COVID-19 associated risks and therapeutic considerations for patients with distinct inherited arrhythmia syndromes and provide recommendations, pending local possibilities, for their monitoring and management during this pandemic."],"journal":"Heart Rhythm","authors":["Wu, Cheng-I","Postema, Pieter G","Arbelo, Elena","Behr, Elijah R","Bezzina, Connie R","Napolitano, Carlo","Robyns, Tomas","Probst, Vincent","Schulze-Bahr, Eric","Remme, Carol Ann","Wilde, Arthur A M"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32244059","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.hrthm.2020.03.024","keywords":["brugada syndrome","covid-19","catecholaminergic polymorphic ventricular tachycardia","long qt syndrome","sars-cov-2","short qt syndrome"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"locations":["Brugada"],"_version_":1664638249360949248,"score":182.48557},{"pmid":32259899,"title":"Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.","text":["Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.","Approximately 90 days of the SARS-CoV-2 (COVID-19) spreading originally from Wuhan, China, and across the globe has led to a widespread chain of events with imminent threats to the fragile relationship between community health and economic health. Despite near hourly reporting on this crisis, there has been no regular, updated, or accurate reporting of hospitalizations for COVID-19. It is known that many test-positive individuals may not develop symptoms or have a mild self-limited viral syndrome consisting of fever, malaise, dry cough, and constitutional symptoms. However some individuals develop a more fulminant syndrome including viral pneumonia, respiratory failure requiring oxygen, acute respiratory distress syndrome requiring mechanical ventilation, and in substantial fractions leading to death attributable to COVID-19. The pandemic is evolving in a clustered, non-inform fashion resulting in many hospitals with preparedness but few or no cases, and others that are completely overwhelmed. Thus, a considerable risk of spread when personal protection equipment becomes exhausted and a large fraction of mortality in those not offered mechanical ventilation are both attributable to a crisis due to maldistribution of resources. The pandemic is amenable to self-reporting through a mobile phone application that could obtain critical information on suspected cases and report on the results of self testing and actions taken. The only method to understand the clustering and the immediate hospital resource needs is mandatory, uniform, daily reporting of hospital censuses of COVID-19 cases admitted to hospital wards and intensive care units. Current reports of hospitalizations are delayed, uncertain, and wholly inadequate. This paper urges all the relevant stakeholders to take up self-reporting and reporting of hospitalizations of COVID-19 as an urgent task in combating this devastating pandemic.","Rev Cardiovasc Med","McCullough, Peter A","Eidt, John","Rangaswami, Janani","Lerma, Edgar","Tumlin, James","Wheelan, Kevin","Katz, Nevin","Lepor, Norman E","Vijay, Kris","Soman, Sandeep","Singh, Bhupinder","McCullough, Sean P","McCullough, Haley B","Palazzuoli, Alberto","Ruocco, Gaetano M","Ronco, Claudio","32259899"],"abstract":["Approximately 90 days of the SARS-CoV-2 (COVID-19) spreading originally from Wuhan, China, and across the globe has led to a widespread chain of events with imminent threats to the fragile relationship between community health and economic health. Despite near hourly reporting on this crisis, there has been no regular, updated, or accurate reporting of hospitalizations for COVID-19. It is known that many test-positive individuals may not develop symptoms or have a mild self-limited viral syndrome consisting of fever, malaise, dry cough, and constitutional symptoms. However some individuals develop a more fulminant syndrome including viral pneumonia, respiratory failure requiring oxygen, acute respiratory distress syndrome requiring mechanical ventilation, and in substantial fractions leading to death attributable to COVID-19. The pandemic is evolving in a clustered, non-inform fashion resulting in many hospitals with preparedness but few or no cases, and others that are completely overwhelmed. Thus, a considerable risk of spread when personal protection equipment becomes exhausted and a large fraction of mortality in those not offered mechanical ventilation are both attributable to a crisis due to maldistribution of resources. The pandemic is amenable to self-reporting through a mobile phone application that could obtain critical information on suspected cases and report on the results of self testing and actions taken. The only method to understand the clustering and the immediate hospital resource needs is mandatory, uniform, daily reporting of hospital censuses of COVID-19 cases admitted to hospital wards and intensive care units. Current reports of hospitalizations are delayed, uncertain, and wholly inadequate. This paper urges all the relevant stakeholders to take up self-reporting and reporting of hospitalizations of COVID-19 as an urgent task in combating this devastating pandemic."],"journal":"Rev Cardiovasc Med","authors":["McCullough, Peter A","Eidt, John","Rangaswami, Janani","Lerma, Edgar","Tumlin, James","Wheelan, Kevin","Katz, Nevin","Lepor, Norman E","Vijay, Kris","Soman, Sandeep","Singh, Bhupinder","McCullough, Sean P","McCullough, Haley B","Palazzuoli, Alberto","Ruocco, Gaetano M","Ronco, Claudio"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259899","week":"202015|Apr 06 - Apr 12","doi":"10.31083/j.rcm.2020.01.42","keywords":["covid-19","sars-cov-2","critical care; mortality","epidemiology","hospitalization","public health","reporting","resource utilization"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640769790574593,"score":174.04758},{"pmid":32314798,"title":"COVID-19 Infection in Patients with Sickle Cell Disease.","text":["COVID-19 Infection in Patients with Sickle Cell Disease.","Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, has spread to 184 countries with almost 1.5 million cases as of mid-April 2020 since first reported (1). The clinical features of this disease are not completely understood, however severe illness is thought to predominantly occur in adults with advanced age and those with underlying comorbidities (2). Sickle cell disease (SCD), an immunocompromised condition, puts patients at higher risk for respiratory infections and subsequent pulmonary complications such as acute chest syndrome (ACS) (3).","Br J Haematol","Hussain, Faiz A","Njoku, Franklin U","Saraf, Santosh L","Molokie, Robert E","Gordeuk, Victor R","Han, Jin","32314798"],"abstract":["Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, has spread to 184 countries with almost 1.5 million cases as of mid-April 2020 since first reported (1). The clinical features of this disease are not completely understood, however severe illness is thought to predominantly occur in adults with advanced age and those with underlying comorbidities (2). Sickle cell disease (SCD), an immunocompromised condition, puts patients at higher risk for respiratory infections and subsequent pulmonary complications such as acute chest syndrome (ACS) (3)."],"journal":"Br J Haematol","authors":["Hussain, Faiz A","Njoku, Franklin U","Saraf, Santosh L","Molokie, Robert E","Gordeuk, Victor R","Han, Jin"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314798","week":"202017|Apr 20 - Apr 26","doi":"10.1111/bjh.16734","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664714520074911746,"score":165.69911},{"pmid":32303607,"title":"British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.","text":["British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.","The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.","Gut","Kennedy, Nicholas A","Jones, Gareth-Rhys","Lamb, Christopher A","Appleby, Richard","Arnott, Ian","Beattie, R Mark","Bloom, Stuart","Brooks, Alenka J","Cooney, Rachel","Dart, Robin J","Edwards, Cathryn","Fraser, Aileen","Gaya, Daniel R","Ghosh, Subrata","Greveson, Kay","Hansen, Richard","Hart, Ailsa","Hawthorne, A Barney","Hayee, Bu'Hussain","Limdi, Jimmy K","Murray, Charles D","Parkes, Gareth C","Parkes, Miles","Patel, Kamal","Pollok, Richard C","Powell, Nick","Probert, Chris S","Raine, Tim","Sebastian, Shaji","Selinger, Christian","Smith, Philip J","Stansfield, Catherine","Younge, Lisa","Lindsay, James O","Irving, Peter M","Lees, Charlie W","32303607"],"abstract":["The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials."],"journal":"Gut","authors":["Kennedy, Nicholas A","Jones, Gareth-Rhys","Lamb, Christopher A","Appleby, Richard","Arnott, Ian","Beattie, R Mark","Bloom, Stuart","Brooks, Alenka J","Cooney, Rachel","Dart, Robin J","Edwards, Cathryn","Fraser, Aileen","Gaya, Daniel R","Ghosh, Subrata","Greveson, Kay","Hansen, Richard","Hart, Ailsa","Hawthorne, A Barney","Hayee, Bu'Hussain","Limdi, Jimmy K","Murray, Charles D","Parkes, Gareth C","Parkes, Miles","Patel, Kamal","Pollok, Richard C","Powell, Nick","Probert, Chris S","Raine, Tim","Sebastian, Shaji","Selinger, Christian","Smith, Philip J","Stansfield, Catherine","Younge, Lisa","Lindsay, James O","Irving, Peter M","Lees, Charlie W"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303607","week":"202016|Apr 13 - Apr 19","doi":"10.1136/gutjnl-2020-321244","keywords":["crohn's colitis","crohn's disease","ulcerative colitis"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China","Italy","GBR","GBR","British"],"countries":["Italy","United Kingdom","China"],"countries_codes":["ITA|Italy","GBR|United Kingdom","CHN|China"],"_version_":1664632934614695937,"score":160.24333},{"pmid":32240279,"title":"Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?","text":["Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?","BACKGROUND: The amelioration of the current COVID pandemic relies on swift and efficient case finding as well as stringent social distancing measures. Current advice suggests that fever or new onset dry cough are the commonest presenting complaints. METHODOLOGY: We present a case report and case series as well as other evidence that there is an important fourth presenting syndrome, namely isolated sudden onset anosmia (ISOA), which should be considered highly suspicious for SARS-CoV-2. RESULTS: A patient presenting with ISOA who went on to test positive for infection with COVID-19 and did not develop any further symptoms as well as a case series of similar patients although limited by the lack of reliable testing at the moment. CONCLUSIONS: We posit the existence of a fourth common syndrome of COVID-19 infection: isolated sudden onset anosmia (ISOA) and urge the international community to consider this presentation in current management advice.","Rhinology","Gane, S B","Kelly, C","Hopkins, C","32240279"],"abstract":["BACKGROUND: The amelioration of the current COVID pandemic relies on swift and efficient case finding as well as stringent social distancing measures. Current advice suggests that fever or new onset dry cough are the commonest presenting complaints. METHODOLOGY: We present a case report and case series as well as other evidence that there is an important fourth presenting syndrome, namely isolated sudden onset anosmia (ISOA), which should be considered highly suspicious for SARS-CoV-2. RESULTS: A patient presenting with ISOA who went on to test positive for infection with COVID-19 and did not develop any further symptoms as well as a case series of similar patients although limited by the lack of reliable testing at the moment. CONCLUSIONS: We posit the existence of a fourth common syndrome of COVID-19 infection: isolated sudden onset anosmia (ISOA) and urge the international community to consider this presentation in current management advice."],"journal":"Rhinology","authors":["Gane, S B","Kelly, C","Hopkins, C"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240279","week":"202014|Mar 30 - Apr 05","doi":"10.4193/Rhin20.114","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664638354247909378,"score":143.12706}]}